BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 129 filers reported holding BIOSCRIP INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $86,000 | +109.8% | 27,765 | +67.5% | 0.00% | – |
| Q1 2018 | $41,000 | -46.1% | 16,579 | -39.8% | 0.00% | -100.0% |
| Q3 2017 | $76,000 | +52.0% | 27,542 | -5.9% | 0.01% | -30.0% |
| Q1 2017 | $50,000 | +150.0% | 29,282 | +54.2% | 0.01% | +42.9% |
| Q4 2016 | $20,000 | -42.9% | 18,986 | +14.8% | 0.01% | -84.4% |
| Q1 2016 | $35,000 | -41.7% | 16,544 | -51.8% | 0.04% | -37.5% |
| Q4 2015 | $60,000 | – | 34,328 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |